COMPARISON OF THE EFFICACY, TOLERABILITY AND SAFETY OF PROPIVERINE FOR THE TREATMENT OF OAB IN YOUNGER VS OLDER PATIENTS (&lt;/≥ 65 YEARS): A POST-HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND STUDY

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 126
	Open Discussion ePosters Scientific Open Discussion Session 7
	Wednesday 14th September 2016
	12:25 - 12:30 (ePoster Station 6)
	ePoster Area
	Overactive Bladder Pharmacology Urgency Urinary Incontinence Clinical Trial
	1. Bladder Center Westend Berlin, Germany, 2. Department of Urology and Pediatric Urology, University of Schleswig Holstein, Campus Kiel, Germany, 3. APOGEPHA Arzneimittel GmbH, Dresden, Germany, 4. Department of Urology and Urological Oncology, Hannover Medical School, Germany
Presenter
E Elke Hessdoerfer
Abstract PDF Edit Abstract Abstract Centre